Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Poland Spain
  • A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Bulgaria Czechia Germany Poland Spain
  • A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Spain +1
  • A Study of Brivekimig Compared to Placebo in Patients with Moderate to Severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Greece Hungary Italy +3
  • A Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa

    Recruiting

    2 1 1
    Investigated Diseases:
    France Germany Ireland Italy Poland Spain
  • Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa

    Recruiting

    2 1
    Investigated Diseases:
    Germany The Netherlands Poland Spain
  • Study on Botulinum Toxin Type A for Treating Hidradenitis Suppurativa in Patients: A Comparison of Different Drug Combinations

    Recruiting

    3 1 1
    Investigated Diseases:
    Denmark
  • Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections

    Recruiting

    3 1 1 1
    Belgium
  • Study on the Effectiveness of Ceftriaxone and Metronidazole Combination for Patients with Hurley Stage 2 Hidradenitis Suppurativa

    Recruiting

    3 1 1
    Investigated Diseases:
    France
  • A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

    Recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Germany Hungary Poland Romania